3 High-Risk, High-Reward Stocks to Add to Your Watch List

3 High-Risk, High-Reward Stocks to Add to Your Watch List

Most investors know that young biotech companies are risky investments. Between the unpredictable drug development process, the high costs of clinical trials, and fierce competition, many fledgling biotechs simply won't survive into adulthood. All three of the companies I'll discuss today are in the process of developing their first therapies and advancing them through clinical trials.